共 56 条
[1]
Ahmadi H(2014)Precystectomy serum levels of carbohydrate antigen 19–9, carbohydrate antigen 125, and carcinoembryonic antigen: prognostic value in invasive urothelial carcinoma of the bladder Urol Oncol 32 648-656
[2]
Djaladat H(2011)HE4 in ovarian cancer: from discovery to clinical application Adv Clin Chem 55 1-20
[3]
Cai J(2018)Evaluation of serum HE4 in ovarian tumors, its comparison with serum CA125 and correlation with histological subtypes Indian J Gynecol Oncolog 16 62-146
[4]
Miranda G(2016)Mesothelin-Targeted CARs: Driving T Cells to solid tumors Cancer Discov 6 133-189
[5]
Daneshmand S(2014)B7 H4 as a potential target for immunotherapy for gynecologic cancers: a closer look Gynecol Oncol 34 181-341
[6]
Montagnana M(2007)B7 H4 is over expressed in early stage ovarian cancer and is independent of CA125 expression Gynecol Oncol 106 334-327
[7]
Danese E(2011)Analysis of the prognostic value of soluble Epidermal Growth factor receptor plasma concentration in advanced non-small-cell lung cancer patients Clin Lung Cancer 12 320-354
[8]
Giudici S(2015)Contributions of the Epidermal Growth factor receptor to acquisition of platinum resistance in ovarian cancer cells PLoS ONE 10 e0136893-2
[9]
Khati S(2016)First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non small cell lung cancer Cochrane Database Syst Rev 25 CD010383-113
[10]
Jaiswal R(2005)ERBB receptors and cancer: the complexity of targeted inhibitors Nat Rev Cancer 5 341-134